Arcturus Therapeutics Holdings (ARCT) Payables: 2018-2025
Historic Payables for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Sep 2025 value amounting to $5.5 million.
- Arcturus Therapeutics Holdings' Payables fell 45.80% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.5 million, marking a year-over-year decrease of 23.33%. This contributed to the annual value of $7.2 million for FY2024, which is 36.28% up from last year.
- As of Q3 2025, Arcturus Therapeutics Holdings' Payables stood at $5.5 million, which was down 48.31% from $10.6 million recorded in Q2 2025.
- Arcturus Therapeutics Holdings' Payables' 5-year high stood at $19.3 million during Q1 2023, with a 5-year trough of $5.3 million in Q4 2023.
- Over the past 3 years, Arcturus Therapeutics Holdings' median Payables value was $10.1 million (recorded in 2024), while the average stood at $10.8 million.
- Per our database at Business Quant, Arcturus Therapeutics Holdings' Payables skyrocketed by 136.36% in 2023 and then tumbled by 52.73% in 2024.
- Quarterly analysis of 5 years shows Arcturus Therapeutics Holdings' Payables stood at $10.1 million in 2021, then decreased by 25.94% to $7.4 million in 2022, then declined by 29.13% to $5.3 million in 2023, then surged by 36.28% to $7.2 million in 2024, then slumped by 45.80% to $5.5 million in 2025.
- Its Payables was $5.5 million in Q3 2025, compared to $10.6 million in Q2 2025 and $6.2 million in Q1 2025.